IMMUNE AND CYTOKINE STATUS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING ALEMTUZUMAB

IMMUNE AND CYTOKINE STATUS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING ALEMTUZUMAB

In present work, we studied cytokine levels and performed analysis of some immunologic parameters in the patients with chronic lymphocytic leukemia (CLL) before and after treatment with monoclonal anti-CD52 antibody (alemtuzumab). In comparison with a control group, the CLL patients before alemtuzum...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. N Khorobrykh, T. P. Zagoskina, V. I. Shardakov, E. L. Nazarova, A. V. Yovdiy
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2014-07-01
Series:	Медицинская иммунология
Subjects:	chronic lymphocytic leukemia cytokines lymphocyte subsets alemtuzumab cd52
Online Access:	https://www.mimmun.ru/mimmun/article/view/408
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Expression of lymphocyte subsets in the bone marrow of patients with acute myeloid leukemia and its influence on prognosis
by: NIE Jinhong, et al.
Published: (2025-07-01)

Treatment of chronic lymphocytic leukaemia and autoimmune complications with antibody targeted to the CD52 antigen (Campath) - the first Russian experience
by: T. E. Byalik, et al.
Published: (2022-11-01)

COMPOSITION OF LYMPHOCYTE SUBSETS IN THE PATIENTS WITH SEVERE FORMS OF HERPETIC INFECTION
by: I. A. Novikova, et al.
Published: (2014-07-01)

Analysis of clinical and laboratory characteristics of six cases with T-cell large granular lymphocytic leukemia
by: LU Hongyu, LIU Hong, SONG Luxi
Published: (2024-12-01)

Bendamustine: a new view on treatment of chronic lymphocytic leukemia
by: Ye. A. Nikitin
Published: (2022-11-01)

Modification of immune response genes in various types of chronic lymphocytic leukemia
by: E. L. Nazarova, et al.
Published: (2015-03-01)

Comparative efficacy of chronic lymphocytic leukemia treatment with or without rituximab
by: E. A. Zenkova, et al.
Published: (2019-12-01)

METABOLIC STATE OF BLOOD LYMPHOCYTES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOID LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

Clinical management of alemtuzumab-induced autoimmune thyroid diseases: a narrative review
by: Jacopo Manso, et al.
Published: (2025-06-01)

Association of Absolute Lymphocyte Count and Circulating CD4+ and CD8+ T-Cells with Positive Clinical Outcome in Survivors of Cancer: An Observational Study
by: Suresh Rao, et al.
Published: (2019-07-01)

Myocardial contractility dysfunction in patients with chronic lymphocytic leukemia receiving chemotherapy and their treatment with enalapril
by: I. L. Davydkin, et al.
Published: (2020-03-01)

The role of alemtuzumab in the development of secondary autoimmunity in multiple sclerosis: a systematic review
by: Sofia Jimenez-Sanchez, et al.
Published: (2024-11-01)

Serum Levels of IL-6 Type Cytokines and Soluble IL-6 Receptors in Active B-Cell Chronic Lymphocytic Leukemia and in Cladribine Induced Remission
by: T. Robak, et al.
Published: (1999-01-01)

Local levels of lymphocytes and cytokines in colon cancer patients with bowel obstruction
by: N. I. Simonenko, et al.
Published: (2025-03-01)

CYTOTOXIC ACTIVITY OF DENDRITIC CELLS AGAINST ACTIVATED CD4+ AND CD8+T-LYMPHOCYTES IN THE CULTURE IN VITRO
by: T. V. Tyrinova, et al.
Published: (2012-05-01)

IMBALANCE OF IMMUNOREGULATORY Th1- AND Th2-CYTOKINES IN PERSISTENT VIRAL INFECTIONS
by: I. O. Naslednikova, et al.
Published: (2014-07-01)

The Effects of Extracted Peptide from Skin of Iraqi Frog (Rana ridibunda) on Human Leukemic Lymphocytes
by: Ali Jabbar Oleiwi Al-Khafaji
Published: (2019-03-01)

Extranodal Manifestation of Chronic Lymphocytic Leukemia: A Case of Bilateral Breast Involvement
by: Ensiyeh Bahadoran, et al.
Published: (2025-06-01)

Diagnostic and therapeutic recommendations of the Polish Society of Haematologists and Transfusiologists and Polish Adult Leukemia Group-CLL for chronic lymphocytic leukemia in 2025
by: Iwona Hus, et al.
Published: (2025-01-01)

Real-world cardiovascular risks of ibrutinib in chronic lymphocytic leukemia: a retrospective study
by: Jelena Ivanovic, et al.
Published: (2025-08-01)

SALMON SOFT ROE DNA ON BLOOD CELLS SECRETION OF CYTOKINES IN HEALTHY DONORS
by: L. N. Fedjanina
Published: (2014-07-01)

Interactions between galectin-3 and cardiovascular risk in patients with chronic lymphocytic leukemia in remission: results of 3-year prospective study
by: B. B. Samura
Published: (2018-10-01)

Chronic Lymphocytic Leukemia: Investigation of Survival and Prognostic Factors with Drug-Related Remission
by: Gökhan Pektaş, et al.
Published: (2025-03-01)

IMMUNITY AND INFECTION IN WOMEN WITH HYPERPLASTIC STATES OF IMMUNE SYSTEM
by: A. A. Lukach, et al.
Published: (2014-07-01)

Vaccination in Patients with Chronic Lymphocytic Leukemia: Current Problems
by: M. I. Kislova, et al.
Published: (2021-07-01)

Pathogen‐specific B‐cell receptors drive chronic lymphocytic leukemia by light‐chain‐dependent cross‐reaction with autoantigens
by: Nereida Jiménez de Oya, et al.
Published: (2017-09-01)

EXPRESSION OF SURFACE MARKERS ON CD4+T-LYMPHOCYTES IN NORMAL PREGNANCY AND PRE-ECLAMPSIA
by: V. A. Mikhailova, et al.
Published: (2014-07-01)

Conventional and non-conventional antigen-binding sites promote the development and function of chronic lymphocytic leukemia stereotyped subset #4 clones
by: Yun Liu, et al.
Published: (2025-08-01)

Immune Signatures of Solid Tumor Patients Treated With Immune Checkpoint Inhibitors: An Observational Study
by: Ling Chen, et al.
Published: (2025-01-01)

Characterisation of Cytotoxicity-Related Receptors on γδ T Cells in Chronic Lymphocytic Leukaemia
by: Michał Zarobkiewicz, et al.
Published: (2025-03-01)

Analysis of the differentiation of peripheral B-lymphocytes in pregnant women with a habitual miscarriage
by: N. Yu. Sotnikova, et al.
Published: (2021-06-01)

Diagnosis of Chronic Lymphocytic Leukemia Using iwCLL 2018 Compared with NCI-WG96 Criteria in Cipto Mangunkusumo Hospital: A Practical Consideration in Resource Limited Setting
by: Lugyanti Sukrisman, et al.
Published: (2023-01-01)

Diagnostic value of miR-485-3p in IgA nephropathy and its correlation with immunological parameters and T lymphocyte subsets
by: Chen Jiang-xiu, et al.
Published: (2022-11-01)

Intratumoral CD8+ tumor-infiltrating lymphocytes as prognostic predictors in radio-chemoradiotherapy-treated nasopharyngeal carcinoma
by: Xinjing Li, et al.
Published: (2025-05-01)

Prognostic factors and effectiveness of the first-line therapy for chronic lymphocytic leukemia: results of 10-year follow-up
by: О. B. Kalashnikova, et al.
Published: (2021-02-01)

METHODS FOR CELLULAR AND MOLECULAR COMPOUND OF ATHEROSCLEROTIC PLAQUES ASSESSMENT: LITERARY REVIEW
by: Yu. V. Saranchina, et al.
Published: (2017-10-01)

THE CHANGES IN SEMEN LYMPHOCYTE SUBPOPULATION’S RATIO IN MEN INFERTILITY
by: A. V. Semenov, et al.
Published: (2014-07-01)

LYMPHOCYTE SUBPOPULATIONS IN GASTRIC AND COLORECTAL CANCER PATIENTS AFTER IMMUNOTHERAPY WITH ACTIVATED LYMPHOCYTES
by: E. V. Abakushina, et al.
Published: (2014-11-01)

Equivalents of the neutrophil-to-lymphocyte ratio of circulating pool of stem and immature hematopoietic cells for assessing liver transplant status
by: A. N. Shutko, et al.
Published: (2023-09-01)

Acalabrutinib in treatment of patients with chronic lymphocytic leukemia including those at high genetic risk
by: Anna Ewa Wolska-Washer, et al.
Published: (2025-01-01)